It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
We herein outline the rationale for a Swedish cohort consortium, aiming to facilitate greater use of Swedish cohorts for world-class research. Coordination of all Swedish prospective population-based cohorts in a common infrastructure would enable more precise research findings and facilitate research on rare exposures and outcomes, leading to better utilization of study participants’ data, better return of funders’ investments, and higher benefit to patients and populations. We motivate the proposed infrastructure partly by lessons learned from a pilot study encompassing data from 21 cohorts. We envisage a standing Swedish cohort consortium that would drive development of epidemiological research methods and strengthen the Swedish as well as international epidemiological competence, community, and competitiveness.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Department of Medical Sciences, Uppsala University, Uppsala, Sweden;; Uppsala Clinical Research Center (UCR), Uppsala, Sweden;
2 Department of Public Health and Community Medicine/Primary Health Care, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;
3 Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden;
4 Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;
5 Department of Medical Sciences, Uppsala University, Uppsala, Sweden;
6 Department of Public Health Sciences, Stockholm University, Stockholm, Sweden;; Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden;
7 Department of Medical and Health Sciences, Division of Community Medicine, Linköping University, Linköping, Sweden;
8 Department of Medicine, Unit of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden;; Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital Huddinge, Huddinge, Sweden;
9 Västerås Centre for Clinical Research, Uppsala University, Uppsala, Sweden;
10 Department of Public Health and Community Medicine/Epidemiology and Social Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;
11 Department of Odontology, School of Dentistry, Umeå University, Umeå, Sweden;
12 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;; Department of Pediatrics, Örebro University Hospital, Örebro University, Örebro, Sweden;
13 Department of Clinical Sciences, Skane University Hospital, Malmö, Lund University, Lund, Sweden;
14 Department of Clinical Sciences, Cancer Epidemiology, Lund University, Lund, Sweden;
15 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;
16 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA;; Seaver Autism Center for Research and Treatment at Mount Sinai, New York, NY, USA;
17 Uppsala Clinical Research Center (UCR), Uppsala, Sweden;
18 Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden;
19 Department of Public Health and Clinical Medicine, and Heart Center, Umeå University, Umeå, Sweden;
20 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;; Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway;; Genetic Epidemiology Group, Folkhälsan Research Center, Faculty of Medicine, Helsinki University, Helsinki, Finland;; Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway;
21 Department of Surgical Sciences, Uppsala University, Uppsala, Sweden;
22 Department of Public Health and Clinical Medicine, Family Medicine, Umeå University, Umeå, Sweden, and;
23 Research Institute of the McGill University Health Centre, Montreal, Canada